Cart
sales@molnova.com
XY028-133
CAS No. 2229974-73-4
XY028-133( —— )
Catalog No. M33174 CAS No. 2229974-73-4
XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 546 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 847 | In Stock |
|
| 50MG | 1460 | In Stock |
|
| 100MG | 2539 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXY028-133
-
NoteResearch use only, not for human use.
-
Brief DescriptionXY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
-
DescriptionXY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity, which consists of ligands for von Hippel-Lindau and CDK.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2229974-73-4
-
Formula Weight1002.23
-
Molecular FormulaC53H67N11O7S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (49.89 mM; Ultrasonic )
-
SMILESCC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCN(CC3)C(=O)CCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(cc3)-c3scnc3C)C(C)(C)C)nc2n(C2CCCC2)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. JIN, Jian， et al. COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER. Patent. US2017/065027.
molnova catalog
related products
-
Urelumab
Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.
-
AKOS025692697
AKOS025692697 is a biochemical.
-
Retinyl propionate
Vitamin A Propionate is an ester compound of vitamin A. In nutritional studies of foals, different doses have different effects on growth, serum biochemistry and hematological indicators. Too high or too low doses will produce adverse effects and are related to the vitamin A concentration in plasma, liver and kidneys.
